Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic.
about
Animal models for Ebola and Marburg virus infectionsCurrent ebola vaccinesEmerging targets and novel approaches to Ebola virus prophylaxis and treatmentEbola virus vaccines: an overview of current approachesAntibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine[Overview of the Ebola vaccines in pre-clinical and clinical development].Experimental vaccines against potentially pandemic and highly pathogenic avian influenza virusesRespiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and FilovirusesProspects for immunisation against Marburg and Ebola viruses.Progress in filovirus vaccine development: evaluating the potential for clinical use.Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody responseFurther characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein.A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence.Potential vaccines and post-exposure treatments for filovirus infections.Modeling pre-existing immunity to adenovirus in rodents: immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine.RNA-based viral vectors.Ebola virus disease candidate vaccines under evaluation in clinical trials.Ebola virus vaccines - reality or fiction?Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green Monkeys.An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models.From bench to almost bedside: the long road to a licensed Ebola virus vaccine.Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola VirusAntibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors
P2860
Q21131118-A1E1FA84-B2AB-4CCA-A8A7-8197D18E90C6Q21534720-7C0F7A0A-9C6E-4EEE-B7B0-F48DE823CABEQ24597625-B124CFC0-D823-4990-BF54-0909FDFED663Q26999232-DB6F71B5-F103-46F0-8717-AB7368B27897Q27334697-5BB7A5E9-5189-4CED-B801-D4C57C604C62Q30245207-11C1F8D9-8675-465D-B248-ED5350C258E9Q30427591-0777714D-48EA-4A01-9C39-77AEBEB13147Q33964142-76035607-F99C-4060-B01A-46248FE8F35FQ35275167-E96B698C-71A0-40D5-89A9-A64728DA5FDDQ36043269-DC0079F2-FE52-4A01-B0CE-CC9A2E74C733Q36088118-0D3AC289-CCA2-4080-BD45-7EEF0EC8BF2FQ36100545-51F2245E-1235-415B-84D2-C6433D418127Q36190519-BD97CD49-E096-46C1-B0ED-E803D8086A97Q36210186-F6A3F324-D64E-4441-AFBC-F54D806BB716Q36356863-EFCBFFC9-A587-462A-8905-32654CA5D140Q36404178-8D2E78BD-190B-49E9-8BF3-FC09B62EEE45Q37627897-FDDF7A95-78CE-4DB6-8F93-D73D8B53D996Q38266413-273C88B8-F3B7-4EC7-AD4E-D0181B188597Q38830109-3905436E-EB8C-487B-98BC-8F74EC13F7B8Q38881265-036ED6BC-1904-49EF-B566-37CF3F8DA82FQ40067156-0DCD2944-DB25-4400-94FF-998B64E1CED3Q40095257-D6894F3E-86EE-4FDD-BAE7-C4EE4322970FQ44106264-AC66DB28-7939-499B-AB5C-BA6AE557514EQ56535662-D2E66473-CDA2-497A-AA5F-DD551997A2E9Q58779740-24E26044-220C-42CF-BEB6-9881E26D6062
P2860
Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mucosal parainfluenza virus-ve ...... ne monkeys and is immunogenic.
@ast
Mucosal parainfluenza virus-ve ...... ne monkeys and is immunogenic.
@en
type
label
Mucosal parainfluenza virus-ve ...... ne monkeys and is immunogenic.
@ast
Mucosal parainfluenza virus-ve ...... ne monkeys and is immunogenic.
@en
prefLabel
Mucosal parainfluenza virus-ve ...... ne monkeys and is immunogenic.
@ast
Mucosal parainfluenza virus-ve ...... ne monkeys and is immunogenic.
@en
P2093
P2860
P921
P1433
P1476
Mucosal parainfluenza virus-ve ...... ne monkeys and is immunogenic.
@en
P2093
Alexander A Bukreyev
Brian R Murphy
Joshua M Dinapoli
Lijuan Yang
Peter L Collins
P2860
P304
P356
10.1016/J.VIROL.2010.01.015
P407
P577
2010-02-02T00:00:00Z